It does not cause dependence, does not interact with GLP-1 receptor agonists, and works through an osmotic mechanism rather than stimulating the colon directly
2017;60(suppl 1):S399
Sample name: the product of the invention (batch number P-110201, specification 0.6g) Preparing a compatible injection: 0.9% sodium chloride injection, manufactured by Chongqing Di kang Yangtze pharmaceutical Co., Ltd 5% glucose injection, manufactured by Tai Ji southwest pharmaceutical industries, Ltd 10% glucose injection, manufactured by Tai Ji southwest pharmaceutical industries, Ltd Water for injection, made by Investigation time: 0h, 2h, 4h and 6h And (4) investigation indexes are as follows: the results of the product of the invention in four injections at ambient temperature conditions (dilution to measured concentration, measured only at 0h, 2h, 4h, 6 h) for clarity, pH, visible foreign matter, insoluble particles, related substances (area normalization) are shown in tables 7-8
Vistanos: Complementos Alimenticios Cosmticos Naturales Equisalud S el primero en opinar
Then, evaluate the wagering requirement on the spin winnings
GLP: Glucagon-Like Peptide-1